Modern Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.41M Buy
22,795
+2,427
+12% +$141K 0.02% 355
2025
Q4
$1.1M Buy
20,368
+1,690
+9% +$81.3K 0.02% 393
2025
Q3
$842K Sell
18,678
-617
-3% -$28.8K 0.02% 420
2025
Q2
$893K Buy
19,295
+869
+5% +$42.7K 0.02% 382
2025
Q1
$1.12M Buy
18,426
+2,608
+16% +$152K 0.04% 291
2024
Q4
$895K Buy
15,818
+3,067
+24% +$171K 0.03% 270
2024
Q3
$660K Buy
+12,751
New +$598K 0.04% 212

Other funds holding BMY

Modern Wealth Management's BMY Position: Q1 2026 in Review

Modern Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q1 2026, buying an estimated $141K and bringing the position to 22,795 shares worth $1.41M. The position accounts for 0.02% of the portfolio, ranked #355.

Modern Wealth Management first reported a position in BMY in Q3 2024 and has held it in 7 quarters since. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Modern Wealth Management held 22,795 shares of Bristol-Myers Squibb worth $1.41M as of Q1 2026.
  • Modern Wealth Management bought 2,427 Bristol-Myers Squibb shares in Q1 2026, an estimated $141K.
  • Bristol-Myers Squibb made up 0.02% of Modern Wealth Management's portfolio in Q1 2026, its #355 holding.
  • Modern Wealth Management first reported a position in Bristol-Myers Squibb in Q3 2024 and has held it in 7 quarters since.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Modern Wealth Management's 13F filing for Q1 2026, filed 14 May 2026.